Citadel Advisors
HSTO

Citadel Advisors’s Histogen Inc. Common Stock HSTO Stock Holding History

Citadel Advisors’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,551
Closed -$24K – 14300
2022
Q2 		$24K Buy
+10,551
New +$37.9K ﹤0.01% 12342
2022
Q1 		– Sell
-2,560
Closed -$17K – 15163
2021
Q4 		$17K Buy
2,560
+838
+49% +$9.58K ﹤0.01% 13612
2021
Q3 		$26K Sell
1,722
-3,026
-64% -$51.2K ﹤0.01% 13609
2021
Q2 		$103K Buy
4,748
+1,074
+29% +$22.3K ﹤0.01% 12906
2021
Q1 		$95K Buy
3,674
+3,136
+583% +$78.8K ﹤0.01% 12511
2020
Q4 		$8K Buy
+538
New +$16.8K ﹤0.01% 10827
2020
Q2 		– Sell
-261
Closed -$16K – 10765
2020
Q1 		$16K Buy
+261
New +$20.4K ﹤0.01% 9354
2019
Q3 		– Sell
-146
Closed -$9.52K – 9985
2019
Q2 		$8K Sell
146
-223
-60% -$38.7K ﹤0.01% 9057
2019
Q1 		$80K Sell
369
-163
-31% -$65.7K ﹤0.01% 8640
2018
Q4 		$184K Buy
532
+212
+66% +$165K ﹤0.01% 7932
2018
Q3 		$371K Buy
320
+51
+19% +$47K ﹤0.01% 7222
2018
Q2 		$230K Buy
269
+82
+44% +$68.1K ﹤0.01% 7651
2018
Q1 		$219K Buy
187
+120
+179% +$133K ﹤0.01% 7215
2017
Q4 		$62K Sell
67
-132
-66% -$122K ﹤0.01% 7566
2017
Q3 		$218K Sell
199
-134
-40% -$152K ﹤0.01% 6565
2017
Q2 		$383K Buy
333
+252
+311% +$307K ﹤0.01% 5514
2017
Q1 		$93K Sell
81
-62
-43% -$59.9K ﹤0.01% 6886
2016
Q4 		$151K Buy
143
+78
+120% +$35.4K ﹤0.01% 6506
2016
Q3 		$26K Buy
65
+3
+5% +$1.22K ﹤0.01% 6987
2016
Q2 		$26K Buy
+62
New +$30.4K ﹤0.01% 6548
2016
Q1 		– Sell
-986
Closed -$568K – 8370
2015
Q4 		$568K Sell
986
-912
-48% -$639K ﹤0.01% 4297
2015
Q3 		$1.69M Buy
1,898
+477
+34% +$435K ﹤0.01% 3157
2015
Q2 		$1.46M Buy
+1,421
New +$1.67M ﹤0.01% 3457

Other funds holding HSTO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Citadel Advisors's HSTO Position: Q3 2022 in Review

Citadel Advisors sold out of Histogen Inc. Common Stock (HSTO) in Q3 2022, closing a stake of 10,551 shares — an estimated $24K sold.

Citadel Advisors first reported a position in HSTO in Q2 2015 and held it in 23 quarters. The position peaked at $1.69M in Q3 2015. 13 funds tracked by Wall St. Rank hold HSTO as of Q3 2022.

  • Citadel Advisors reported no remaining Histogen Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Citadel Advisors sold 10,551 Histogen Inc. Common Stock shares in Q3 2022, an estimated $24K.
  • Citadel Advisors first reported a position in Histogen Inc. Common Stock in Q2 2015 and held it in 23 quarters.
  • Citadel Advisors's Histogen Inc. Common Stock position peaked at $1.69M in Q3 2015.
  • 13 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q3 2022.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.